The Leukemia & Lymphoma Society's (LLS's) Research Oversight Committees are comprised of leading experts in their fields. Committee members are volunteers who give their time and talent to LLS and receive no compensation for their generous support.
Medical & Scientific Affairs Committee
Advises the Board of Directors on a range of issues, including recommending funding for research grant awards and periodically reviewing LLS’s medical affairs
Jonathan D. Licht, MD (Chair)
UF Gainesville
Stephen Ansell, MD, PhD
Mayo Clinic, Rochester
Leif Bergsagel, MD
Mayo Clinic, Arizona
Ravi Bhatia, MD
The University of Alabama at Birmingham
Catherine Bollard, MD
Georgetown University
Lori Brown, PhD, MPH
FDA, Investigations Branch (formerly)
Renzo Canetta, MD +
Bristol-Myers Squibb (formerly)
Giulio Draetta, MD, PhD
The University of Texas MD Anderson Cancer Center
Christopher Flowers, MD +
The University of Texas MD Anderson Cancer Center
Janice Gabrilove, MD +
Mount Sinai
Irene Ghobrial, MD
Dana-Farber Cancer Institute
Larry Kwak, MD, PhD
City of Hope
Ruben Mesa, MD +
UT Health San Antonio
David Weinstock, MD
Dana-Farber Cancer Institute
Therapy Acceleration Program Committee
Provides oversight and guidance on LLS’s Therapy Acceleration Program (TAP), a strategic initiative through which LLS partners directly with biotechnology companies and medical institutions to help accelerate the development of promising therapies
Casey Cunningham, MD (Chair) +
Santé Ventures
Giulio Draetta, MD, PhD
The University of Texas MD Anderson Cancer Center
Christoper Flowers, MD, MS, FASCO +
The University of Texas MD Anderson Cancer Center
Patrick Fortune, PhD, MBA
Partners Heathcare Systems
Laura Kaufman, PhD, DABT
Private Consultant
Ronald Levy, MD
Stanford University School of Medicine
Vern Norviel, Esq.
Wilson Sonsini Goodrich & Rosati
Robert Rosen, JD +
Grewhawke Capital Advisors
Steven Rosen, MD, FACP
City of Hope
Robert Spiegel, MD, FACP
Spiegel Consulting LLC
David Weinstock, MD
Dana-Farber Cancer Institute
+ National Board Member